The role of glucuronidation in N-(3,5-dichlorophenyl)succinimide (NDPS) nephrotoxicity: Nephrotoxic potential of NDPS and NDPS metabolites in Gunn, Wistar, and Fischer 344 rats

Toxicology and Applied Pharmacology

Volumn 154, Issue 2, 1999, Pages 170-180

  Hong, Suk K ^a   Anestis, Dianne K ^a   Skaggs, Christopher ^a   Brown, Patrick I ^a   Rankin, Gary O ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fungicide; Glucuronidation; Gunn rats; Nephrotoxicity; Rats; Succinimide

Indexed keywords

FUNGICIDE; N (3,5 DICHLOROPHENYL)SUCCINIMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOTRANSFORMATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; GLUCURONIDATION; MALE; NEPHROTOXICITY; NONHUMAN; RAT; TOXICITY TESTING;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0033556547     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8554     Document Type: Article

References (64)

1. Aleo M. D., Rankin G. O., Cross T. J., Schnellmann R. G. Toxicity ofN. Chem.-Biol. Interact. 78:1991;109-121.
2. Baba W. I., Lant A. F., Smith A. J., Townshend M. M., Wilson G. M. Pharmacological effects in animals and normal human subjects of the diuretic amiloride hydrochloride (MK-870). Clin. Pharmacol. Ther. 9:1968;318-327.
3. Baer J. E., Jones C. B., Spitzer S. A., Russo H. F. The potassium-sparing and natriuretic activity ofN. J. Pharmacol. Exp. Ther. 157:1967;472-485.
4. Barrett M. C., Cashman S. J., Moss J. Experimental interstitial renal fibrosis in rats: Nephritis induced byN. Br. J. Exp. Pathol. 64:1983;425-435.
5. Beers K. W., Nicoll D. W., Anestis D. K., Brown P. I., Rankin G. O. Effect of microsomal enzyme modulators onN. Toxicology. 84:1993;141-155.
6. Beers K. W., Rankin G. O. Effect ofN. Toxicology. 79:1993;139-148.
7. Bock K. W., Frohling W., Remmer H., Rexer B. Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim. Biophys. Acta. 327:1973;46-56.
8. Bradford M. M. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
9. Coughtrie M. W. H., Burchell B., Shepherd L. M., Bend J. R. Defective induction of phenol glucuronidation by 3-methylcholanthrene in Gunn rats is due to the absence of a specific UDP-glucuronosyltransferase isoenzyme. Mol. Pharmacol. 31:1987;585-591.
10. Dickinson R. G., Verbeeck R. K., King A. R. Absence of phenolic glucuronidation and enhanced hydroxylation of diflunisal in the homozygous Gunn rat. Xenobiotica. 21:1991;1535-1546.
11. Fujinami A., Ozaki T., Nodera K., Tanaka K. Studies on biological activity of cyclic imide compounds. Part II. Antimicrobial activity of 1-phenylpyrrolidine-2,5-diones and related compounds. Agric. Biol. Chem. 36:1972;318-323.
12. Fujinami A., Ozaki T., Yamamoto S. Studies on biological activity of cyclic imide compounds. Part I. Antimicrobial activity of 3-phenyloxazolidine-2,4-diones and related compounds. Agric. Biol. Chem. 35:1971;1707-1719.
13. Goon D., Klaassen C. D. Effects of microsomal enzyme inducers upon UDP-glucuronic acid concentration and UDP-glucuronosyltransferase activity in the rat intestine and liver. Toxicol. Appl. Pharmacol. 115:1992;253-260.
14. Gunn C. H. Hereditary acholuric jaundice in a new mutant strain of rats. J. Hered. 29:1938;137-139.
15. Hansen-Moller J., Cornett C., Dalgaard L., Hansen S. H. Isolation and identification of the rearrangement products of diflunisal 1-O. J. Pharmaceut. Biomed. Anal. 6:1988;229-240.
16. Harvison P. J., Griffith R. J., Teets V. J., Nicoll D. W., Brown P. I., Rankin G. O. Nephrotoxic potential ofNN. Toxicol. Lett. 60:1992;221-226.
17. Hasegawa J., Smith P. C., Benet L. Z. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug Metab. Disp. 10:1982;469-473.
18. Heaton J. B. Control of brown rot and transit rot of peaches with post-harvest fungicidal dips. Queensl. J. Agric. Anim. Sci. 37:1980;155-159.
19. Henesey C. M., Harvison P. J. Potential metabolism and cytotoxicity ofN. Toxicology. 104:1995;9-16.
20. Hong S. K., Anestis D. K., Brown P. I., Rankin G. O. Effect of glucuronidation substrates/inhibitors onN. Toxicology. 1998.
21. Hu Z., Wells P. G. In vitroin vivoa. J. Pharmacol. Exp. Ther. 263:1992;334-342.
22. Igarashi T., Irokawa N., Ono S., Ohmori S., Ueno K., Kitagawa H., Satoh T. Difference in the effects of phenobarbital and 3-methylcholanthrene treatment on subunit composition of hepatic glutathioneS. Xenobiotica. 17:1987;127-137.
23. Ito N., Sugihara S., Makiura S., Arai M., Hirao K., Denda A., Nishio O. Effect ofN. Gann. 65:1974;131-138.
24. Kacew S., Ruben Z., McConnell R.F. Strain as a determinant factor in the differential responsiveness of rats to chemicals. Toxicol. Pathol. 23:1995;701-714.
25. Kretz-Rommel A., Boelsterili U. A. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to P450-mediated acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol. 120:1993;155-161.
26. Krijgsheld K. R., Koster H. J., Scholtens E., Mulder G. J. The cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate. J. Pharmacol. Exp. Ther. 221:1982;731-734.
27. Lin J. H., Chen I.-W., Ulm E. H., Duggan D. E. Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats. J. Pharmacol. Exp. Ther. 242:1987;1013-1018.
28. Magdalou J., Chajes V., Lafaurie C., Siest G. Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes. Drug Metab. Disp. 18:1990;692-697.
29. Martinez-Maldonado M., Suki W. N., Schenker S. Nature of the urinary concentrating defect in the Gunn strain of rat. Am. J. Physiol. 216:1969;1386-1391.
30. McGurk K. A., Remmel R. P., Hosagrahara V. P., Tosh D., Burchell B. Reactivity of mefenamic acid 1-Oin vitroex vivo. Drug Metab. Disp. 24:1996;842-849.
31. Mulder G. J. Glucuronidation and its role in regulation of biological activity of durgs. Annu. Rev. Pharmacol. Toxicol. 32:1992;25-49.
32. Mulder G. J., Coughtrie M. W., Burchell B. Glucuronidation. Conjugation Reactions in Drug Metabolism: An Integrated Approach. 1990;Taylor & Francis, London. p. 51-105.
33. Mulder G. J., Hinson J. A., Gillette J. R. Generation of reactive metabolites ofN. Biochem. Pharmacol. 26:1977;189-196.
34. Nyarko N., Harvison P. J. Metabolism of the nephrotoxicantN. Drug Metab. Dispos. 23:1995;107-112.
35. Odell G. B., Natzschka J. C., Storey G. N. B. Bilirubin nephropathy in the Gunn strain of rat. Am. J. Physiol. 212:1967;931-938.
36. Ohkawa H., Hisada Y., Fujiwara N., Miyamoto J. Metabolism ofN. Agric. Biol. Chem. 38:1974;1359-1369.
37. Owen R. A., Heywood R. Strain-related susceptibility to nephrotoxicity induced by aspirin and phenylbutazone in rats. Toxicol. Pathol. 14:1986;242-246.
38. Pickett C. B., Telakowski-Hopkins C. A., Ding G. J.-F., Argenbright L., Lu A. Y.-H. Rat liver glutathioneSS. J. Biol. Chem. 259:1984;5182-5188.
39. Rankin G. O. Nephrotoxicity following acute administration ofN. Toxicology. 23:1982;21-31.
40. Rankin G. O., Cressey-Veneziano K., Brown P. I. Onset and recovery from acuteN. Toxicology. 30:1984;209-216.
41. Rankin G. O., Hong S. K., Dial L. D., Anestis D. K. Effects of chloramphenicol, dehydroepiandrosterone (DHEA) and 2,6-dichloro-4-nitrophenol(DCNP) onN. Toxicologist. 30:1996;303.
42. Rankin G. O., Hong S. K., Valentovic M. A., Anestis D. K., Dial L. D., Ball J. G. Effect of inhibitors of glucuronide conjugation onN. ISSX Proc. 8:1995;183.
43. Rankin G. O., Shih H. C., Teets V. J., Yang D. J., Nicoll D. W., Brown P. I. N. Toxicology. 68:1991a;307-325.
44. Rankin G. O., Shih H. C., Yang D. J., Richmond C. D., Teets V. J., Brown P. I. Nephrotoxicity ofNin vivoin vitro. Toxicol. Appl. Pharmacol. 96:1988;405-416.
45. Rankin G. O., Teets V. J., Nicoll D. W., Brown P. I. Effect of buthionine sulfoximine on acuteN. Toxicol. Lett. 52:1990;91-100.
46. Rankin G. O., Teets V. J., Nicoll D. W., Brown P. I. Effect of buthionine sulfoximine onNN. Toxicol. Lett. 57:1991b;297-308.
47. Rankin G. O., Yang D. J., Cressey-Veneziano K., Brown P. I. N. Toxicol. Lett. 24:1985;99-105.
48. Rankin G. O., Yang D. J., Richmond C. D., Teets V. J., Wang R. T., Brown P. I. Effect of microsomal enzyme activity modulation onN. Toxicology. 45:1987a;269-289.
49. Rankin G. O., Yang D. J., Teets V. J., Brown P. I. Deuterium isotope effect in acuteN. Life Sci. 39:1986;1291-1299.
50. Rankin G. O., Yang D. J., Teets V. J., Lo H. H., Brown P. I. The effect of probenecid on acuteN. Toxicology. 44:1987b;181-192.
51. Savina P. M., Brouwer K. L. R. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat. Drug Metab. Dispos. 20:1992;496-501.
52. Scragg I., Celier C., Burchell B. Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronosyltransferase enzyme protein. FEBS Lett. 183:1985;37-42.
53. Shih H., Rankin G. O. Convenient synthesis ofN. Synthesis. 11:1989;866-867.
54. Shinohara Y., Arai M., Hirao K., Sugihara S., Nakanishi K., Tsunoda H., Ito N. Combination effect of citrinin and other chemicals on rat kidney tumorigenesis. Gann. 67:1976;147-155.
55. Shinohara Y., Miyata Y., Murasaki G., Nakanishi K., Takashi Y., Ito N. Effect ofN. Gann. 68:1977;397-404.
56. Spahn-Langguth H., Benet L. Z. Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism. Drug Metab. Rev. 24:1992;5-48.
57. Sugihara S., Shinohara Y., Miyata Y., Inoue K., Ito N. Pathologic analysis of chemical nephritis in rats induced byN. Lab. Invest. 33:1975;219-230.
58. Takayama C., Fujinami A. Quantitative structure-activity relationships of antifungalNN. Pestic. Biochem. Physiol. 12:1979;163-171.
59. Tomlin C. The Pesicide Manual: Incorporating The Agrochemicals Handbook. 1994;The Bath PressBritish Crop Protection Council, Bath.
60. Vore M., Durham S., Yeh S., Ganguly T. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol 17′-β(β-d. Biochem. Pharmacol. 41:1991;431-437.
61. Vree T. B., Van den Biggelaar-Martea M., Van Ewijk-Beneken Kolmer E. W. J., Hekster Y. A. Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment. Pharm. World Sci. 15:1993;165-170.
62. Watkins J. B., Klaassen C. D. Induction of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16Ó-carbonitrile. Drug Metab. Disp. 10:1982;590-594.
63. Yang D. J., Richmond C. D., Teets V. J., Brown P. I., Rankin G. O. Effect of succinimide ring modification onN. Toxicology. 37:1985;65-77.
64. Yang D. J., Teets V. J., Bolton B., Brown P. I., Rankin G. O. Role of glutathione in acuteN. Toxicology. 45:1987;25-44.